Sarah Cappuyns: Neoadjuvant Immunotherapy in HCC at ESMO GI 2026
Sarah Cappuyns/LinkedIn

Sarah Cappuyns: Neoadjuvant Immunotherapy in HCC at ESMO GI 2026

Sarah Cappuyns, Clinical Research Fellow – GI Oncology at Imperial College London, shared a post on LinkedIn:

“Check out our poster on neoadjuvant immunotherapy in HCC at ESMO GI 2026.

With the ever-inspiring leadership and support of David James Pinato.

I promise you its worth a look !”

Other articles featuring Sarah Cappuyns on OncoDaily.